OSTEOPHARM INC has a total of 30 patent applications. Its first patent ever was published in 1994. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are JOHNSON LESLIE S, HUMABS LLC and HUMANIGEN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | United States | 5 | |
#3 | Australia | 3 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Bulgaria | 1 | |
#7 | Brazil | 1 | |
#8 | China | 1 | |
#9 | Czechia | 1 | |
#10 | Hungary | 1 | |
#11 | Israel | 1 | |
#12 | Iceland | 1 | |
#13 | Morocco | 1 | |
#14 | Mexico | 1 | |
#15 | Norway | 1 | |
#16 | New Zealand | 1 | |
#17 | Poland | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Tam Cherk Shing | 24 |
#2 | Peel Sean Alexander Fitzgerald | 2 |
#3 | Tam Cherk S | 2 |
#4 | Gu Yaoming | 1 |
#5 | Shing-Tam Cherk | 1 |
Publication | Filing date | Title |
---|---|---|
WO2007107003A1 | Markers for the diagnosis, monitoring and prognosis of osteoporosis and for assessing the risk for osteoporosis and for osteoporotic fractures | |
WO2006007682A1 | Polypeptides for use in ameliorating effects of aging in mammals | |
WO2004050701A1 | Bone growth factor | |
US6815421B1 | Polypeptides for use in ameliorating effects of aging in mammals | |
AU5379200A | Bone stimulating factor | |
US6693081B2 | Bone stimulating factor | |
US6352973B1 | Bone stimulating factor |